Publication | Closed Access

Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol–cyproterone acetate

Reproductive HealthGynecologyPolycystic Ovary SyndromeFemale Reproductive FunctionMenstrual CycleReproductive EndocrinologyFemale InfertilityWomen's PhysiologyPublic HealthMenopause Hormone TherapyCardiovascular Risk ParametersEstradiol–cyproterone AcetateEndocrinologyPharmacologyOvarian HormoneCardiovascular DiseaseMenopauseMedicineWomen's Health